0001209191-23-052650.txt : 20231011
0001209191-23-052650.hdr.sgml : 20231011
20231011172520
ACCESSION NUMBER: 0001209191-23-052650
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231006
FILED AS OF DATE: 20231011
DATE AS OF CHANGE: 20231011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cunningham, Richard Anthony
CENTRAL INDEX KEY: 0001624783
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40388
FILM NUMBER: 231321377
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE, BUILDING 200 SUITE 2
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anebulo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001815974
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851170950
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: JFL CAPITAL MANAGEMENT
STREET 2: 1017 RR 620 S, SUITE 107
CITY: LAKEWAY
STATE: TX
ZIP: 78734
BUSINESS PHONE: 737 203 5270
MAIL ADDRESS:
STREET 1: JFL CAPITAL MANAGEMENT
STREET 2: 1017 RR 620 S, SUITE 107
CITY: LAKEWAY
STATE: TX
ZIP: 78734
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-10-06
0
0001815974
Anebulo Pharmaceuticals, Inc.
ANEB
0001624783
Cunningham, Richard Anthony
C/O ANEBULO PHARMACEUTICALS, INC.
1017 RANCH ROAD 620 SOUTH, STE. 107
LAKEWAY
TX
78734
1
1
0
0
Chief Executive Officer
0
Stock Option (right to buy)
3.0271
2023-10-06
4
A
0
600000
0.00
A
2033-10-05
Common Stock
600000
600000
D
The shares subject to the option will vest and become exercisable as follows: ratably in 16 quarterly installments (37,500 per installment) on the first day of each calendar quarter commencing with January 1, 2024, such that option will be full vested on October 1, 2027.
/s/ Daniel George, Attorney-in-Fact
2023-10-11